1.         Ok E, Akcicek F, Coker A, Tombuloğlu M, Toz H, Tokat Y, Cirit M, Tobu M, Onder G, Basci A. Alloimmune haemolytic anaemia after renal transplantation. Nephrol Dial Transplant. 1995;10(3):404-5. PubMed PMID: 7792041.

2.         Ok E, Akçiçek F, Töz H, Kürşat S, Töbü M, Başçi A, Mees EJ. Comparison of the effects of enalapril and theophylline on polycythemia after renal transplantation. Transplantation. 1995 Jun 15;59(11):1623-6. PubMed PMID: 7778179.

3.         Ok E, Akcicek F, Toz H, Coker A, Kursat S, Tokat Y, Arac N. Goitre and severe autonomic neuropathy due to secondary amyloidosis in a renal transplant patient. Clin Nephrol. 1996 May;45(5):361-2. PubMed PMID: 8738674.

4.         Akcicek F, Ozkahya M, Cirit M, Ok E, Unsal A, Toz H, Celik A, Atabay G, Basci A. The efficiency of fractionated parenteral iron treatment in CAPD patients. Adv Perit Dial. 1997;13:109-12. PubMed PMID: 9360661.

5.         Töz H, Ok E, Unsal A, Aşçi G, Başdemir G, Başçi A. Effectiveness of pulse cyclophosphamide plus oral steroid therapy in idiopathic membranoproliferative glomerulonephritis. Nephrol Dial Transplant. 1997 May;12(5):1081-2. PubMed PMID: 91

6.         Ozerkan F, Töz H, Ozkahya M, Cirit M, Soydaş CC. Hypervolemia in dialysispatients–Doppler echocardiography studies. Nephrol Dial Transplant. 1998 Aug;13(8):2151-3. PubMed PMID: 9719190.75081.

7.         Töz H, Ozerkan F, Unsal A, Soydas C, Dorhout Mees EJ. Dilated uremic cardiomyopathy in a dialysis patient cured by persistent ultrafiltration. Am J Kidney Dis. 1998 Oct;32(4):664-8. PubMed PMID: 9774132.

8.         Sayiner A, Kürşat S, Töz H, Duman S, Onal B, Tümbay E. Pseudomembranous necrotizing bronchial aspergillosis in a renal transplant recipient. Nephrol Dial Transplant. 1999 Jul;14(7):1784-5. PubMed PMID: 10435898.

9.         Töz H, Ozkahya M, Dorhout Mees EJ. Long-term evolution of cardiomyopathy in dialysis patients. Kidney Int. 1999 Jul;56(1):350-1. PubMed PMID: 10438253.

10.       Ozkahya M, Töz H, Unsal A, Ozerkan F, Asci G, Gürgün C, Akçiçek F, Mees EJ. Treatment of hypertension in dialysis patients by ultrafiltration: role of cardiac dilatation and time factor. Am J Kidney Dis. 1999 Aug;34(2):218-21.PubMed PMID: 10430965.

11.       Celik A, Ok E, Unsal A, Töz H, Atabay G. Comparison of enalapril and losartan in the treatment of posttransplant erythrocytosis. Nephron. 2000 Nov;86(3):394-5. PubMed PMID: 11096321.

12.       Günal AI, Duman S, Ozkahya M, Töz H, Asçi G, Akçiçek F, Basçi A. Strict volume control normalizes hypertension in peritoneal dialysis patients. Am J Kidney Dis. 2001 Mar;37(3):588-93. PubMed PMID: 11228184.

13.       Duman S, Töz H, Aşçi G, Alper S, Ozkahya M, Unal I, Celik A, Ok E, Başçi A. Successful treatment of post-transplant Kaposi’s sarcoma by reduction of immunosuppression. Nephrol Dial Transplant. 2002 May;17(5):892-6. PubMed PMID:11981080.

14.       Töz H, Ok E, Yilmaz F, Akarca US, Erensoy S, Zeytinoğlu A, Ozkahya M, Karasu Z, Yüce G, Başçi A. Clinicopathological features of hepatitis C virus infection in dialysis and renal transplantation. J Nephrol. 2002 May-Jun;15(3):308-12.PubMed PMID: 12116989.

15.       Cavusoglu C, Cicek-Saydam C, Karasu Z, Karaca Y, Ozkahya M, Toz H, Tokat Y, Bilgic A. Mycobacterium tuberculosis infection and laboratory diagnosis in solid-organ transplant recipients. Clin Transplant. 2002 Aug;16(4):257-61. PubMed PMID: 12099981.

16.       Ozkahya M, Toz H, Qzerkan F, Duman S, Ok E, Basci A, Mees EJ. Impact of volume control on left ventricular hypertrophy in dialysis patients. J Nephrol.2002 Nov-Dec;15(6):655-60. PubMed PMID: 12495279.

17.       Ozkalay N, Ozacar T, Aşçi G, Töz H, Kansoy S. [Human herpesvirus 6 infections in kidney and bone marrow/stem cell transplant recipients]. Mikrobiyol Bul. 2003 Apr-Jun;37(2-3):179-86. Turkish. PubMed PMID: 14593901.

18.       Sen S, Duman S, Sarsik B, Toz H, Zeytinoglu A. Cytomegalovirus infection in renal allograft biopsy. Ann Saudi Med. 2003 Sep-Oct;23(5):306-11. PubMed PMID:16868403.

19.       Töz H, Sen S, Seziş M, Duman S, Ozkahya M, Ozbek S, Hoşcoşkun C, Atabay G, Ok E. Comparison of tacrolimus and cyclosporin in renal transplantation by the protocol biopsies. Transplant Proc. 2004 Jan-Feb;36(1):134-6. PubMed PMID:15013324.

20.       Duman S, Ozbek S, Sen S, Tamsel S, Töz H, Aşçi G, Ozkahya M, Seziş M, Ok E, Hoşcoşkun C. Is "zero-hour" biopsy of the transplanted kidney risky? Transplant Proc. 2004 Jan-Feb;36(1):137-8. PubMed PMID: 15013325.

21.       Töz H, Duman S, Altunel E, Seziş M, Ozbek S, Ozkahya M, Aşci G, Ok E, Başci A. Intima media thickness as a predictor of atherosclerosis in renaltransplantat ion. Transplant Proc. 2004 Jan-Feb;36(1):156-8. PubMed PMID:15013331.

22.       Duman S, Aşçi G, Töz H, Ozkahya M, Ertilav M, Seziş M, Ok E. Patients with failed renal transplant may be suitable for peritoneal dialysis. Int Urol Nephrol. 2004;36(2):249-52. PubMed PMID: 15368705.

23.       Dirlik A, Ozbek SS, Toz H, Hoscoskun C, Ozcan Z. Localization of accessory renal artery infarction using Tc-99m DMSA scintigraphy. Clin Nucl Med. 2004 Oct;29(10):649-51. PubMed PMID: 15365444.

24.       Atasever A, Bacakoglu F, Toz H, Basoglu OK, Duman S, Basak K, Guzelant A, Sayiner A. Tuberculosis in renal transplant recipients on various immunosuppressive regimens. Nephrol Dial Transplant. 2005 Apr;20(4):797-802. Epub 2005 Feb 9. PubMed PMID: 15703207.

25.       Alper S, Kilinc I, Duman S, Toz H, Ceylan C, Unal I, Aytimur D. Skin diseases in Turkish renal transplant recipients. Int J Dermatol. 2005 Nov;44(11):939-41. PubMed PMID: 16336528.

26.       Aşci G, Ozkahya M, Duman S, Toz H, Erten S, Ok E. Volume control associated with better cardiac function in long-term peritoneal dialysis patients. Perit Dial Int. 2006 Jan-Feb;26(1):85-8. PubMed PMID: 16538880.

27.       Asci G, Toz H, Ozkahya M, Cagirgan S, Duman S, Sezis M, Ok E. High-dose immunoglobulin therapy in renal transplant recipients with hemophagocytic histiocytic syndrome. J Nephrol. 2006 May-Jun;19(3):322-6. PubMed PMID: 16874692.

28.       Ozkahya M, Ok E, Toz H, Asci G, Duman S, Basci A, Kose T, Dorhout Mees EJ. Long-term survival rates in haemodialysis patients treated with strict volüme control. Nephrol Dial Transplant. 2006 Dec;21(12):3506-13. Epub 2006 Sep 25.PubMed PMID: 17000733.

29.       Töz H, Ozkahya M, Ozerkan F, Aşçi G, Ok E. Improvement in "uremic" cardiomyopathy by persistent ultrafiltration. Hemodial Int. 2007 Jan;11(1):46-50. PubMed PMID: 17257356.

30.       Bostanci N, Ilgenli T, Emingil G, Afacan B, Han B, Töz H, Atilla G, Hughes FJ, Belibasakis GN. Gingival crevicular fluid levels of RANKL and OPG in periodontal diseases: implications of their relative ratio. J Clin Periodontol.2007 May;34(5):370-6. Epub 2007 Mar 13. PubMed PMID: 17355365.

31.       Bostanci N, Ilgenli T, Emingil G, Afacan B, Han B, Töz H, Berdeli A, Atilla G, McKay IJ, Hughes FJ, Belibasakis GN. Differential expression of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin mRNA in periodontal diseases. J Periodontal Res. 2007 Aug;42(4):287-93. PubMed PMID: 17559623.

32.       Aydin U, Yazici P, Toz H, Hoscoskun C, Coker A. Management of small bowel volvulus in a patient with simultaneous pancreas-kidney transplantation (SPKT): a case report. J Med Case Rep. 2007 Sep 28;1:106. PubMed PMID: 17903265; PubMed Central PMCID: PMC2117004.

33.       Demirci C, Sen S, Sezak M, Sarsik B, Hoşcoşkun C, Töz H. Incidence and importance of c4d deposition in renal allograft dysfunction. Transplant Proc.2008 Jan-Feb;40(1):174-7. doi: 10.1016/j.transproceed.2007.11.055. PubMed PMID:18261578.

34.       Nart A, Sipahi S, Aykas A, Uslu A, Hoşcoşkun C, Toz H. Efficacy and safety of enteric-coated mycophenolate sodium in de novo and maintenance renal transplant patients. Transplant Proc. 2008 Jan-Feb;40(1):189-92. doi:10.1016/j.transproceed.2007.11.066. PubMed PMID: 18261583.

35.       Emingil G, Afacan B, Tervahartiala T, Töz H, Atilla G, Sorsa T. Gingival crevicular fluid and serum matrix metalloproteinase-8 and tissue inhibitor of matrix metalloproteinase-1 levels in renal transplant patients undergoing different immunosuppressive therapy. J Clin Periodontol. 2008 Mar;35(3):221-9. doi: 10.1111/j.1600-051X.2007.01192.x. PubMed PMID: 18269661.

36.       Mominadam S, Ozkahya M, Kayikcioglu M, Toz H, Asci G, Duman S, Ergin P, Kirbiyik S, Ok E, Basci A. Interdialytic blood pressure obtained by ambulatory blood pressure measurement and left ventricular structure in hypertensive hemodialysis patients. Hemodial Int. 2008 Jul;12(3):322-7. doi:10.1111/j.1542-4758.2008.00275.x. PubMed PMID: 18638087.

37.       Gürkan A, Afacan B, Emingil G, Töz H, Başkesen A, Atilla G. Gingival crevicular fluid transforming growth factor-beta1 in cyclosporine and tacrolimus treated renal transplant patients without gingival overgrowth. Arch Oral Biol.2008 Aug;53(8):723-8. doi: 10.1016/j.archoralbio.2008.02.003. Epub 2008 Mar 14.PubMed PMID: 18342291.

38.       Asci G, Basci A, Shah SV, Basnakian A, Toz H, Ozkahya M, Duman S, Ok E. Carbamylated low-density lipoprotein induces proliferation and increases adhesion molecule expression of human coronary artery smooth muscle cells. Nephrology (Carlton). 2008 Dec;13(6):480-6. doi: 10.1111/j.1440-1797.2008.00948.x. Epub 2008 Jun 1. PubMed PMID: 18518940.

39.       Emingil G, Afacan B, Tervahartiala T, Töz H, Atilla G, Sorsa T. By mistakes we learn: determination of matrix metalloproteinase-8 and tissue inhibitor of matrix metalloproteinase-1 in serum yields doubtful results. J Clin Periodontol. 2008 Dec;35(12):1087-8. doi: 10.1111/j.1600-051X.2008.01336.x. Epub 2008 Oct 28. PubMed PMID: 18983634.

40.       Aydoğan O, Gürgün A, Başoğlu OK, Aşçi G, Ertilav M, Bacakoğlu F, Töz H, Güzelant A, Sayiner A. [Tuberculin skin test reactivity in patients with chronic renal failure]. Tuberk Toraks. 2009;57(3):268-76. Turkish. PubMed PMID: 19787465

41.       Demirci MS, Ozkahya M, Asci G, Sevinc E, Yilmaz M, Demirci C, Toz H, Basci A, Ok E. The influence of dialysate calcium on progression of arterial stiffness in peritoneal dialysis patients. Perit Dial Int. 2009 Feb;29 Suppl 2:S15-7. PubMed PMID: 19270206.

42.       Uslu A, Töz H, Sen S, Alkan FT, Nart A, Aykas A, Doğan M, Postaci H, Sahin T,Simşek C. Late conversion from calcineurin inhibitor-based to sirolimus-based immunosuppression due to chronic toxicity: a prospective study with protocol biopsy amendment. Transplant Proc. 2009 Mar;41(2):756-63. doi:10.1016/j.transproceed.2009.01.044. PubMed PMID: 19328973.

43.       Kayikcioglu M, Tumuklu M, Ozkahya M, Ozdogan O, Asci G, Duman S, Toz H, Can LH, Basci A, Ok E. The benefit of salt restriction in the treatment of end-stage renal disease by haemodialysis. Nephrol Dial Transplant. 2009 Mar;24(3):956-62.doi: 10.1093/ndt/gfn599. Epub 2008 Nov 11. PubMed PMID: 19004849.

44.       Asberg A, Humar A, Jardine AG, Rollag H, Pescovitz MD, Mouas H, Bignamini A, Töz H, Dittmer I, Montejo M, Hartmann A; VICTOR Study Group. Long-term outcomes of CMV disease treatment with valganciclovir versus IV ganciclovir in solid organ transplant recipients. Am J Transplant. 2009 May;9(5):1205-13. doi:10.1111/j.1600-6143.2009.02617.x. PubMed PMID: 19422345.

45.       Töz H, Nart D, Turan I, Ersöz G, Seziş M, Aşçi G, Ozkahya M, Zeytinoğlu A, Erensoy S, Ok E. The acquisition time of infection: a determinant of the severity of hepatitis C virus-related liver disease in renal transplant patients. Clin Transplant. 2009 Sep-Oct;23(5):723-31. doi: 10.1111/j.1399-0012.2009.01017.x.Epub 2009 Jun 30. PubMed PMID: 19573091.

46.       Gürkan A, Emingil G, Oktem G, Selvi N, Afacan B, Tunç Ilgenli, Töz H, Atilla G. Immunohistochemical analysis of inducible and endothelial forms of nitric oxide synthase in cyclosporin A-induced gingival overgrowth. J Periodontol. 2009 Oct;80(10):1638-47. doi: 10.1902/jop.2009.090138. PubMed PMID: 19792854.

47.       Celik G, Sen S, Sipahi S, Akkin C, Tamsel S, Töz H, Hoscoskun C. Regressive course of oxalate deposition in primary hyperoxaluria after kidney transplantation. Ren Fail. 2010;32(9):1131-6. doi: 10.3109/0886022X.2010.509900. PubMed PMID: 20863224.

48.       Kotton CN, Kumar D, Caliendo AM, Asberg A, Chou S, Snydman DR, Allen U, Humar A; Transplantation Society International CMV Consensus Group. International consensus guidelines on the management of cytomegalovirus in solid organ transplantation. Transplantation. 2010 Apr 15;89(7):779-95. doi:10.1097/TP.0b013e3181cee42f. PubMed PMID: 20224515.

49.       Ozdogan O, Kayikcioglu M, Asci G, Ozkahya M, Toz H, Sezis M, Can LH, Ok E. Left atrial volume predicts mortality in low-risk dialysis population on long-term low-salt diet. Am Heart J. 2010 Jun;159(6):1089-94. doi:10.1016/j.ahj.2010.03.020. PubMed PMID: 20569724.

50.       Yilmaz M, Nart A, Sen S, Tasli F, Uslu A, Hur E, Ozkahya M, Hoscoskun C, Toz H. Progression of graft fibrosis under mammalian target of rapamycin inhibitor-based regimen. Nephrology (Carlton). 2010 Sep;15(6):653-8. doi:10.1111/j.1440-1797.2010.01365.x. PubMed PMID: 20883287.

51.       Demirci MS, Toz H, Yilmaz F, Ertilav M, Asci G, Ozkahya M, Zeytinoglu A, Nart D, Ok E. Risk factors and consequences of post-transplant diabetes mellitus. Clin Transplant. 2010 Sep-Oct;24(5):E170-7. doi: 10.1111/j.1399-0012.2010.01247.x.PubMed PMID: 20384711.

52.       Emingil G, Afacan B, Tervahartiala T, Töz H, Atilla G, Sorsa T. GCF and serum myeloperoxidase and matrix metalloproteinase-13 levels in renal transplant patients. Arch Oral Biol. 2010 Oct;55(10):719-27. doi: 10.1016/j.archoralbio.2010.06.011. Epub 2010 Jul 15. PubMed PMID: 20637451.

53.       Gungor O, Kircelli F, Carrero JJ, Asci G, Toz H, Tatar E, Hur E, Sever MS, Arinsoy T, Ok E. Endogenous testosterone and mortality in male hemodialysis patients: is it the result of aging? Clin J Am Soc Nephrol. 2010 Nov;5(11):2018-23. doi: 10.2215/CJN.03600410. Epub 2010 Jul 22. PubMed PMID:20651153; PubMed Central PMCID: PMC3001774.

54.       Celik G, Demirci MS, Tumuklu M, Ascı G, Sipahi S, Toz H, Bascı A, Ok E. Factors related to pulse wave velocity and augmentation index in chronic hemodialysis patients. Ren Fail. 2011;33(10):957-63. doi:10.3109/0886022X.2011.615967. Epub 2011 Sep 9. PubMed PMID: 21902600.

55.       Tatar E, Gungor O, Firat O, Kircelli F, Arda B, Harman M, Toz H, Hoscoskun C. Differential diagnosis of an unusual pelvic mass in a renal transplant recipient: multidrug-resistant abdominopelvic tuberculosis. Ren Fail. 2011;33(10):1040-2. doi: 10.3109/0886022X.2011.618921. PubMed PMID: 22013939.

56.       Gungor O, Kircelli F, Demirci MS, Tuncel P, Sisman AR, Tatar E, Hur E, Asci G, Ok E, Toz H. Serum paraoxonase 1 activity predicts arterial stiffness in renal transplant recipients. J Atheroscler Thromb. 2011;18(10):901-5. Epub 2011 Jul 6. PubMed PMID: 21737961.

57.       Kircelli F, Asci G, Yilmaz M, Sevinc Ok E, Demirci MS, Toz H, Akcicek F, Ok E, Ozkahya M. The impact of strict volume control strategy on patient survival and technique failure in peritoneal dialysis patients. Blood Purif. 2011;32(1):30-7. doi: 10.1159/000323038. Epub 2011 Feb 3. PubMed PMID: 21293119.

58.       Ozen KP, Asci G, Gungor O, Carrero JJ, Kircelli F, Tatar E, Sevinc Ok E, Ozkahya M, Toz H, Cirit M, Basci A, Ok E. Nutritional state alters the association between free triiodothyronine levels and mortality in hemodialysis patients. Am J Nephrol. 2011;33(4):305-12. doi: 10.1159/000324883. Epub 2011 Mar 8. PubMed PMID: 21389695.

59.       Hur E, Gungor O, Musayev O, Usta M, Toz H, Asci G, Ozkahya M, Duman S, Ok E. Bioimpedance spectroscopy for the detection of hypervolemia in peritoneal dialysis patients. Adv Perit Dial. 2011;27:65-70. PubMed PMID: 22073832.

60.       Asci G, Ok E, Savas R, Ozkahya M, Duman S, Toz H, Kayikcioglu M, Branscum AJ, Monier-Faugere MC, Herberth J, Malluche HH. The link between bone and coronary calcifications in CKD-5 patients on haemodialysis. Nephrol Dial Transplant. 2011 Mar;26(3):1010-5. doi: 10.1093/ndt/gfq491. Epub 2010 Aug 13. PubMed PMID:20709740; PubMed Central PMCID: PMC3108347.

61.       Gungor O, Sen S, Kircelli F, Yilmaz M, Sarsik B, Ozkahya M, Hoscoskun C, Ok E, Toz H. Plasmapheresis therapy in renal transplant patients: five-year experience. Transplant Proc. 2011 Apr;43(3):853-7. doi:10.1016/j.transproceed.2011.03.025. PubMed PMID: 21486614.

62.       Ok E, Duman S, Asci G, Tumuklu M, Onen Sertoz O, Kayikcioglu M, Toz H, Adam SM, Yilmaz M, Tonbul HZ, Ozkahya M; Long Dialysis Study Group. Comparison of 4-and 8-h dialysis sessions in thrice-weekly in-centre haemodialysis: a prospective, case-controlled study. Nephrol Dial Transplant. 2011 Apr;26(4):1287-96. doi: 10.1093/ndt/gfq724. Epub 2010 Dec 9. PubMed PMID: 21148270.

63.       Toz H, Sen S, Celik HA, Yilmaz M, Hur E, Hoscoskun C, Ozkahya M, Aydin HH. Calcineurin inhibitor-based and free regimens have distinct gene expression patterns in subclinical graft fibrosis. Ann Transplant. 2011 Apr-Jun;16(2):76-87. PubMed PMID: 21716190.

64.       Gungor O, Kircelli F, Carrero JJ, Hur E, Demirci MS, Asci G, Toz H. The effect of immunosuppressive treatment on arterial stiffness and matrix Gla protein levels in renal transplant recipients. Clin Nephrol. 2011 Jun;75(6):491-6. PubMed PMID: 21612751.

65.       Gungor O, Kircelli F, Tatar E, Toz H. Icodextrin-associated hepatotoxicity. NDT Plus. 2011 Aug;4(4):278. doi: 10.1093/ndtplus/sfr065. PubMed PMID: 25949504; PubMed Central PMCID: PMC4421436.

66.       Holdaas H, Rostaing L, Serón D, Cole E, Chapman J, Fellstrøm B, Strom EH, Jardine A, Midtvedt K, Machein U, Ulbricht B, Karpov A, O’Connell PJ; ASCERTAIN Investigators. Conversion of long-term kidney transplant recipients from calcineurin inhibitor therapy to everolimus: a randomized, multicenter, 24-month study. Transplantation. 2011 Aug 27;92(4):410-8. doi: 10.1097/TP.0b013e318224c12d.

67.       Celik G, Töz H, Ertilav M, Aşgar N, Ozkahya M, Başci A, Hoşcoşkun C. Biochemical parameters, renal function, and outcome of pregnancy in kidney transplant recipient. Transplant Proc. 2011 Sep;43(7):2579-83. doi:10.1016/j.transproceed.2011.06.041. PubMed PMID: 21911126.

68.       Tatar E, Kircelli F, Asci G, Carrero JJ, Gungor O, Demirci MS, Ozbek SS, Ceylan N, Ozkahya M, Toz H, Ok E. Associations of triiodothyronine levels with carotid atherosclerosis and arterial stiffness in hemodialysis patients. Clin J Am Soc Nephrol. 2011 Sep;6(9):2240-6. doi: 10.2215/CJN.02540311. Epub 2011 Aug 11. PubMed PMID: 21836150; PubMed Central PMCID: PMC3358995.

69.       Becerik S, Gürkan A, Afacan B, Özgen Öztürk V, Atmaca H, Töz H, Atilla G, Emingil G. Gingival crevicular fluid osteocalcin, N-terminal telopeptides, and calprotectin levels in cyclosporin A-induced gingival overgrowth. J Periodontol. 2011 Oct;82(10):1490-7. doi: 10.1902/jop.2011.100600. Epub 2011 Feb 22. PubMed PMID: 21342006.

70.       Erten S, Gungor O, Sen S, Ozbek SS, Kircelli F, Hoscoskun C, Toz H, Asci G, Basci A, Ok E. Nephrosclerosis and carotid atherosclerosis: lessons from kidney donor histology. Nephrology (Carlton). 2011 Nov;16(8):720-4. doi:10.1111/j.1440-1797.2011.01499.x. PubMed PMID: 21777346.

71.       Gungor O, Kircelli F, Turan MN, Cetin O, Elbi H, Tatar E, Sertoz OO, Toz H. Irritable bowel syndrome in renal transplant patients: prevalence, link with quality of life, anxiety, and depression. Ren Fail. 2012;34(7):876-9. doi: 10.3109/0886022X.2012.690805. Epub 2012 Jun 8. PubMed PMID: 22680982.

72.       Dheir H, Ozkahya M, Kircelli F, Sezis Demirci M, Asci G, Toz H, Ertilav M, Kose T, Ok E. Glycosylated hemoglobin levels are associated with cardiovascular events in nondiabetic peritoneal dialysis patients. J Nephrol. 2012 Jan-Feb;25(1):107-12. doi: 10.5301/JN.2011.8350. PubMed PMID: 21607914.

73.       Demirci MS, Gungor O, Kircelli F, Carrero JJ, Tatar E, Demirci C, Kayikcioglu M, Asci G, Toz H, Ozkahya M, Ok E. Impact of mean arterial pressure on progression of arterial stiffness in peritoneal dialysis patients under strict volume control strategy. Clin Nephrol. 2012 Feb;77(2):105-13. doi: 10.5414/CN107223. PubMed PMID: 22257540.

74.       Demirci MS, Celik G, Ozkahya M, Tumuklu M, Toz H, Asci G, Duman S, Basci A, Kircelli F, Ozdogan O, Demirci C, Can L, Isik IO, Ok E; Long Dialysis Group. Effects of thrice weekly nocturnal hemodialysis on arterial stiffness. Atherosclerosis. 2012 Feb;220(2):477-85. doi: 10.1016/j.atherosclerosis.2011.11.015. Epub 2011 Nov 19. PubMed PMID: 22172590.

75.       Solak I, Sezer TO, Toz H, Tatar E, Sozbilen M, Firat O, Hoscoskun C. What kind of changes occurred in clinical characteristics of deceased kidney donor recipients after national allocation system in Turkey? A single-center retrospective analysis. Transplant Proc. 2012 Jul-Aug;44(6):1598-600. doi: 10.1016/j.transproceed.2012.05.030. PubMed PMID: 22841223.

76.       Tatar E, Turan MN, Firat O, Sezer TO, Sozbilen M, Solak I, Toz H, Hoscoskun C. Use of kidney donors with hepatitis B, hepatitis C, or brain tumor: a single-center experience. Transplant Proc. 2012 Jul-Aug;44(6):1601-3. doi:10.1016/j.transproceed.2012.04.028. PubMed PMID: 22841224.

77.       Sezer TO, Solak I, Toz H, Kardaslar B, Er A, Hoscoskun C. Long-term outcomes of kidney transplants with multiple renal arteries: a retrospective study. Transplant Proc. 2012 Jul-Aug;44(6):1697-9. doi:10.1016/j.transproceed.2012.04.026. PubMed PMID: 22841246.

78.       Solak I, Sezer TO, Toz H, Tatar E, Isayev C, Firat O, Hoscoskun C. Spousal versus living unrelated renal transplantation: a retrospective analysis of allograft outcomes. Transplant Proc. 2012 Jul-Aug;44(6):1710-2. doi:10.1016/j.transproceed.2012.05.069. PubMed PMID: 22841250.

79.       Sevinc Ok E, Kircelli F, Asci G, Altunel E, Ertilav M, Sipahi S, Bozkurt D, Duman S, Ozkahya M, Toz H, Ok E. Neither oxidized nor anti-oxidized low-density lipoprotein level is associated with atherosclerosis or mortality in hemodialysis patients. Hemodial Int. 2012 Jul;16(3):334-41. doi: 10.1111/j.1542-4758.2012.00683.x. Epub 2012 Apr 13. PubMed PMID: 22497657.

80.       Gungor O, Kircelli F, Carrero JJ, Hur E, Dheir H, Simsir A, Okmen F, Toz H, Hoscoskun C. Congenital adrenal hyperplasia: a rare cause of renal failure and a successful renal transplantation. Clin Nephrol. 2012 Aug;78(2):145-8. PubMedPMID: 22790459.

81.       Sevinc Ok E, Asci G, Kircelli F, Duman S, Dheir H, Sezis Demirci M, Ozkahya M, Toz H, Ok E. Relationship between glucose exposure via peritoneal dialysis solutions and coronary artery calcification in non-diabetic peritoneal dialysis patients. Int Urol Nephrol. 2012 Dec;44(6):1847-53. doi: 10.1007/s11255-012-0138-8. Epub 2012 Feb 18. PubMed PMID: 22350838.

82.       Sarsik B, Sen S, Kirdok FS, Akarca US, Toz H, Yilmaz F. Hepatic amyloidosis: morphologic spectrum of histopathological changes in AA and nonAA amyloidosis.Pathol Res Pract. 2012 Dec 15;208(12):713-8. doi: 10.1016/j.prp.2012.07.011. Epub2012 Nov 13. PubMed PMID: 23154038.

83.       Gungor O, Kismali E, Sisman AR, Kircelli F, Carrero JJ, Tatar E, Asci G, Toz H. The relationships between serum sTWEAK, FGF-23 levels, and carotid atherosclerosis in renal transplant patients. Ren Fail. 2013;35(1):77-81. doi:10.3109/0886022X.2012.734890. Epub 2012 Oct 26. PubMed PMID: 23101788.

84.       Turan MN, Yaprak M, Bilgin M, Tatar E, Tamer AF, Nalbantgil S, Özkahya M, Töz H. The evidence of occult hypervolemia; improvement of cardiac functions after kidney transplantation. Ren Fail. 2013;35(5):718-20. doi:10.3109/0886022X.2013.780616. Epub 2013 Apr 8. PubMed PMID: 23560874.

85.       Ok E, Asci G, Toz H, Ok ES, Kircelli F, Yilmaz M, Hur E, Demirci MS, Demirci C, Duman S, Basci A, Adam SM, Isik IO, Zengin M, Suleymanlar G, Yilmaz ME,Ozkahya M; Turkish Online Haemodiafiltration Study. Mortality and cardiovascular events in online haemodiafiltration (OL-HDF) compared with high-flux dialysis:results from the Turkish OL-HDF Study. Nephrol Dial Transplant. 2013 Jan;28(1):192-202. doi: 10.1093/ndt/gfs407. Epub 2012 Dec 9. PubMed PMID:23229932.

86.       Gungor O, Kircelli F, Asci G, Carrero JJ, Tatar E, Demirci MS, Ozbek SS, Ceylan N, Toz H, Ozkahya M, Ok E. Soluble TWEAK level: is it a marker for cardiovascular disease in long-term hemodialysis patients? J Nephrol. 2013 Jan-Feb;26(1):136-43. doi: 10.5301/jn.5000121. PubMed PMID: 2250525

87.       Tatar E, Sarsik B, Gungor O, Yaman B, Ozsan N, Cagirgan S, Sezis Demirci M,Ozgur Sezer T, Hoscoskun C, Toz H. Multiple unrelated malignancies followingrenal transplantation: an evaluation of four cases. Intern Med. 2013;52(6):673-7.Epub 2013 Mar 15. PubMed PMID: 23503409.

88.       Gungor O, Kircelli F, Kitis O, Asci G, Toz H, Ok E. Can strict volume control be the key for treatment and prevention of posterior reversible encephalopathy syndrome in hemodialysis patients? Hemodial Int. 2013 Jan;17(1):107-10. doi:10.1111/j.1542-4758.2012.00672.x. Epub 2012 Feb 23. PubMed PMID: 22360471.

89.       Gungor O, Demirci MS, Kircelli F, Tatar E, Sipahi S, Hur E, Sen S, Toz H,Basci A, Ok E. Increased arterial stiffness in patients with nephrotic syndrome. Clin Nephrol. 2013 Jan;79(1):1-6. doi: 10.5414/CN107760. PubMed PMID: 22948122.

90.       Turan MN, Gungor O, Asci G, Kircelli F, Acar T, Yaprak M, Ceylan N, Demirci MS, Bayraktaroglu S, Toz H, Ozkahya M, Ok E. Epicardial adipose tissue volume and cardiovascular disease in hemodialysis patients. Atherosclerosis. 2013 Jan;226(1):129-33. doi: 10.1016/j.atherosclerosis.2012.10.061. Epub 2012 Nov 6.PubMed PMID: 23159099.

91.       Demirci C, Ozkahya M, Demirci MS, Asci G, Kose T, Colak T, Duman S, Toz H, Ergin P, Adam SM, Ok E. Effects of three times weekly eight-hour nocturnal hemodialysis on volume and nutritional status. Am J Nephrol. 2013;37(6):559-67.doi: 10.1159/000351182. Epub 2013 May 30. PubMed PMID: 23735837.

92.       Tatar E, Kircelli F, Demirci MS, Turan MN, Gungor O, Asci G, Ozkahya M, Ok E, Hoscoskun C, Toz H. Pre-transplant HbA1c level as an early marker for new-onset diabetes after renal transplantation. Int Urol Nephrol. 2013 Feb;45(1):251-8. doi: 10.1007/s11255-012-0304-z. Epub 2012 Oct 7. PubMed PMID: 23054321.

93.       Tatar E, Gungor O, Celtik A, Sisman AR, Yaprak M, Asci G, Ozkahya M, Toz H. Correlation between serum YKL-40 (chitinase-3-like protein 1) level and proteinuria in renal transplant recipients. Ann Transplant. 2013 Mar 8;18:95-100.doi: 10.12659/AOT.883844. PubMed PMID: 23792508.

94.       Yaprak M, Turan MN, Sezer TÖ, Tatar E, Sözbilen EM, Töz H, Hoşcoşkun C. Use of suicidal deaths as kidney donors: a single-center experience. Transplant Proc.2013 Apr;45(3):872-4. doi: 10.1016/j.transproceed.2013.02.053. PubMed PMID:23622574.

95.       Celtik A, Alpay N, Celik A, Sezer TO, Turkmen A, Camsari T, Toz H, Sever MS, Hoscoskun C; Turkish Society of Nephrology Kidney Transplantation Working Group. Kidney transplant recipients with functioning grafts for more than 15 years. Transplant Proc. 2013 Apr;45(3):904-7. doi: 10.1016/j.transproceed.2013.02.051.PubMed PMID: 23622583.

96.       Tanrisev M, Asci G, Gungor O, Kircelli F, Sevinc Ok E, Yilmaz M, Sahin OZ, Ozen KP, Suleymanlar G, Toz H, Ok E. Relation between serum estradiol levels and mortality in postmenopausal female hemodialysis patients. Int Urol Nephrol. 2013 Apr;45(2):503-10. doi: 10.1007/s11255-012-0171-7. Epub 2012 Apr 18. PubMed PMID: 22528584.

97.       Gungor O, Kircelli F, Toz H. Paraoxonase 1, atherosclerosis and arterial stiffness in renal patients. Int Urol Nephrol. 2013 Apr;45(2):441-7. doi:10.1007/s11255-012-0197-x. Epub 2012 Jun 6. Review. PubMed PMID: 22669508.

98.       Gungor O, Tanrisev M, Kircelli F, Turan MN, Tugmen C, Tatar E, Toz H. The effects of mammalian target of rapamycin inhibitors on serum uric acid levels in renal transplant patients. Int Urol Nephrol. 2013 Apr;45(2):547-52. doi:10.1007/s11255-012-0214-0. Epub 2012 Jun 30. PubMed PMID: 22752451.

99.       Hur E, Usta M, Toz H, Asci G, Wabel P, Kahvecioglu S, Kayikcioglu M, Demirci MS, Ozkahya M, Duman S, Ok E. Effect of fluid management guided by bioimpedance spectroscopy on cardiovascular parameters in hemodialysis patients: a randomized controlled trial. Am J Kidney Dis. 2013 Jun;61(6):957-65. doi:10.1053/j.ajkd.2012.12.017. Epub 2013 Feb 15. PubMed PMID: 23415416.

100.     Gungor O, Kismali E, Sisman AR, Kircelli F, Asci G, Topal K, Sipahi S, Tuncel P, Ozkahya M, Toz H. The associations between serum paraoxonase 1 activity and carotid atherosclerosis in renal transplant patients. Clin Nephrol. 2013 Sep;80(3):198-202. doi: 10.5414/CN107855. PubMed PMID: 23547806.

101.     Cobanoglu AK, Gungor O, Kircelli F, Altunel E, Asci G, Ozbek SS, Toz H, Ok E.Role of asymmetric dimethylarginine in the progression of carotid atherosclerosis in renal transplant patients. Int Urol Nephrol. 2013 Oct;45(5):1463-9. doi:10.1007/s11255-012-0345-3. Epub 2012 Dec 5. PubMed PMID: 2321214

102.     Sezer TO, Solak I, Sozbilen M, Firat O, Yilmaz M, Toz H, Sarsik B, Isayev C, Harman M, Hoscoskun C. A horseshoe kidney from a live donor as a renal transplant: case report. Exp Clin Transplant. 2013 Oct;11(5):454-7. doi:10.6002/ect.2012.0214. Epub 2013 Feb 22. PubMed PMID: 23431980.

103.     Turan MN, Tatar E, Yaprak M, Arda B, Kitiş Ö, Metin DY, Hoşcoşkun C, Töz H. A mucormycosis case presented with orbital apex syndrome and hemiplegia in a renal transplant patient. Int Urol Nephrol. 2013 Dec;45(6):1815-9. doi:10.1007/s11255-012-0295-9. Epub 2012 Sep 30. PubMed PMID: 23054315.

104.     Yazici B, Yazici A, Oral A, Akgün A, Toz H. Comparison of renal transplant scintigraphy with renal resistance index for prediction of early graft dysfunction and evaluation of acute tubular necrosis and acute rejection. Clin Nucl Med. 2013 Dec;38(12):931-5. doi: 10.1097/RLU.0000000000000271. PubMed PMID: 24152633.

105.     Yaprak M, Çeltik A, Turan İ, Nart D, Turan MN, Sezer TÖ, Hoşçoşkun C, Töz H. Rare cause of weight loss in a kidney transplant recipient: iron overload. Ren Fail. 2014 Feb;36(1):119-22. doi: 10.3109/0886022X.2013.832860. Epub 2013 Sep 24.PubMed PMID: 24059653.

106.     Colak H, Sert I, Kurtulmus Y, Karaca C, Toz H, Kursat S. The relation between serum testosterone levels and cardiovascular risk factors in patients with kidney transplantation and chronic kidney disease. Saudi J Kidney Dis Transpl. 2014 Sep;25(5):951-9. PubMed PMID: 25193890.

107.     Ok ES, Asci G, Toz H, Ritz E, Kircelli F, Sever MS, Ozkahya M, Sipahi S, Dheir H, Bozkurt D, Omer Z, Sahin OZ, Ertilav M, Ok E. Glycated hemoglobin predicts overall and cardiovascular mortality in non-diabetic hemodialysis patients. Clin Nephrol. 2014 Sep;82(3):173-80. PubMed PMID: 25079862.

108.     Ertilav M, Ozkul A, Zeytinoğlu A, Sen S, Sipahi S, Töz H, Kitiş O, Eraslan C.[Meningoencephalitis caused by West Nile virus in a renal transplant recipient]. Mikrobiyol Bul. 2014 Oct;48(4):674-82. Turkish. PubMed PMID: 25492663.

109.     Doganavsargil B, Buberal GE, Toz H, Sarsik B, Pehlivanoglu B, Sezak M, Sen S.Digitally reinforced hematoxylin-eosin polarization technique in diagnosis of rectal amyloidosis. World J Gastroenterol. 2015 Feb 14;21(6):1827-37. doi:10.3748/wjg.v21.i6.1827. PubMed PMID: 25684948; PubMed Central PMCID: PMC4323459.

110.     Tanrısev M, Hoşcoşkun C, Aşçı G, Sözbilen M, Fırat Ö, Ertilav M, Özkahya M,Töz H. Long-term outcome of kidney transplantation from elderly living andexpanded criteria deceased donors. Ren Fail. 2015 Mar;37(2):249-53. doi:10.3109/0886022X.2014.982488. Epub 2014 Dec 3. PubMed PMID: 25470081

111.     Türkoğlu O, Gürkan A, Emingil G, Afacan B, Töz H, Kütükçüler N, Atilla G. Are antimicrobial peptides related to cyclosporine A-induced gingival overgrowth? Arch Oral Biol. 2015 Mar;60(3):508-15. doi: 10.1016/j.archoralbio.2014.12.007.Epub 2014 Dec 23. PubMed PMID: 25555253.

112.     Uslu A, Hür E, Şen Ç, Şen S, Akgün A, Taşlı FA, Nart A, Yilmaz M, Töz H. To what extent estimated or measured GFR could predict subclinical graft fibrosis: a comparative prospective study with protocol biopsies. Transpl Int. 2015 May;28(5):575-81. doi: 10.1111/tri.12534. Epub 2015 Feb 27. PubMed PMID:25639483.

113.     Celebi ZK, Akturk S, Erdogmus S, Kemaloglu B, Toz H, Polat KY, Keven K. Urgency Priority in Kidney Transplantation: Experience in Turkey. Transplant Proc. 2015 Jun;47(5):1269-72. doi: 10.1016/j.transproceed.2015.04.034. PubMed PMID: 26093696.

114.     Uguz A, Unsal MG, Unalp OV, Sezer T, Celtik A, Sozbilen M, Toz H, Hoscoskun C. Is a High Body Mass Index Still a Risk Factor for Complications of Donor Nephrectomy? Transplant Proc. 2015 Jun;47(5):1291-3. doi: 10.1016/j.transproceed.2015.04.061. PubMed PMID: 26093700.

115.     Colak H, Sert I, Ekmekcı C, Tugmen C, Kurtulmus Y, Kursat S, Töz H. Correlation of the Volume Control Parameters With Health Related Quality of Life in Renal Transplant Patients. Transplant Proc. 2015 Jun;47(5):1369-72. doi:10.1016/j.transproceed.2015.04.012. PubMed PMID: 2609372

116.     Unsal MG, Yilmaz M, Sezer T, Celtik A, Unalp OV, Uguz A, Alci E, Tamer AF, Hoscoskun C, Toz H. Comparison of Preemptive Kidney Transplantation With Nonpreemptive Kidney Transplantation in a Single Center: A Follow-up Study. Transplant Proc. 2015 Jun;47(5):1385-7. doi: 10.1016/j.transproceed.2015.04.039. PubMed PMID: 26093724.

117.     Alci E, Ustun M, Sezer T, Yilmaz M, Ozdemir M, Unsal MG, Uguz A, Sozbilen M, Toz H, Hoscoskun C. Comparison of Patients in Whom Double-J Stent Had Been Placed or Not Placed After Renal Transplantation in a Single Center: A Follow-up Study. Transplant Proc. 2015 Jun;47(5):1433-6. doi: 10.1016/j.transproceed.2015.04.064. PubMed PMID: 26093736.

118.     Tatar E, Sen S, Harman M, Kircelli F, Gungor O, Sarsik B, Asci G, Hoscoskun C, Basci A, Toz H. The relationship between renal volume and histology in obese and nonobese kidney donors. Eur J Clin Invest. 2015 Jun;45(6):565-71. doi:10.1111/eci.12444. Epub 2015 May 10. PubMed PMID: 25845420.

119.     Yazici B, Oral A, Gokalp C, Akgün A, Toz H, Ozbek SS, Yazici A. Evaluation of Renal Transplant Scintigraphy and Resistance Index Performed Within 2 Days After Transplantation in Predicting Long-Term Graft Function. Clin Nucl Med. 2015 Jul;40(7):548-52. doi: 10.1097/RLU.0000000000000789. PubMed PMID: 25899587.

120.     Yazici B, Oral A, Gokalp C, Akgün A, Toz H, Hoscoskun C. A New Quantitative Index for Baseline Renal Transplant Scintigraphy With 99mTc-DTPA in Evaluation of Delayed Graft Function and Prediction of 1-Year Graft Function. Clin Nucl Med. 2016 Mar;41(3):182-8. doi: 10.1097/RLU.0000000000001020. PubMed PMID: 26447378.

121.     Çeltİk A, Şen S, Tamer AF, Yılmaz M, Sarsık B, Özkahya M, Başçı A, Töz H. Recurrent lupus nephritis after transplantation: Clinicopathological evaluation with protocol biopsies. Nephrology (Carlton). 2016 Jul;21(7):601-7. doi:10.1111/nep.12657. PubMed PMID: 26482014.

122.     Demirci C, Aşcı G, Demirci MS, Özkahya M, Töz H, Duman S, Sipahi S, Erten S, Tanrısev M, Ok E. Impedance ratio: a novel marker and a powerful predictor of mortality in hemodialysis patients. Int Urol Nephrol. 2016 Jul;48(7):1155-62.doi: 10.1007/s11255-016-1292-1. Epub 2016 Apr 19. PubMed PMID: 27093965.

123.     Ok E, Asci G, Bayraktaroglu S, Toz H, Ozkahya M, Yilmaz M, Kircelli F, Sevinc Ok E, Ceylan N, Duman S, Cirit M, Monier-Faugere MC, Malluche HH. Reduction of Dialysate Calcium Level Reduces Progression of Coronary Artery Calcification and Improves Low Bone Turnover in Patients on Hemodialysis. J Am Soc Nephrol. 2016Aug;27(8):2475-86. doi: 10.1681/ASN.2015030268. Epub 2015 Dec 23. PubMed PMID:26701977; PubMed Central PMCID: PMC4978036.

124.     Çeltik A, Şen S, Yılmaz M, Demirci MS, Aşçı G, Tamer AF, Sarsık B, Hoşcoşkun C, Töz H, Ok E. The effect of hypercalcemia on allograft calcification after kidney transplantation. Int Urol Nephrol. 2016 Nov;48(11):1919-1925. Epub 2016 Aug 13. PubMed PMID: 27522659.

125.     Yılmaz M, Uçar SK, Aşçı G, Canda E, Tan FA, Hoşcoşkun C, Çoker M, Töz H.Preliminary Screening Results of Fabry Disease in Kidney Transplantation Patients: A Single-Center Study. Transplant Proc. 2017 Apr;49(3):420-424. doi:10.1016/j.transproceed.2017.01.025. PubMed PMID: 28340804.

126.     Yilmaz M, Sezer TÖ, Günay E, Solak I, Çeltik A, Hoşcoşkun C, Töz H. Efficacy and Safety of ATG-Fresenius as an Induction Agent in Living-Donor KidneyTransplantation. Transplant Proc. 2017 Apr;49(3):481-485. doi:10.1016/j.transproceed.2017.02.005. PubMed PMID: 28340817.

127.     Yilmaz M, Sezer TÖ, Kir O, Öztürk A, Hoşcoşkun C, Töz H. Use of ATG-Fresenius as an Induction Agent in Deceased-Donor Kidney Transplantation. Transplant Proc. 2017 Apr;49(3):486-489. doi: 10.1016/j.transproceed.2017.02.006. PubMed PMID:28340818.

128.     Kır O, Zeytinoğlu A, Arda B, Yılmaz M, Aşçı G, Töz H. Impact of Prophylaxis vs Pre-emptive Approach for Cytomegalovirus Infection in Kidney Transplant Recipients. Transplant Proc. 2017 Apr;49(3):537-540. doi:10.1016/j.transproceed.2017.01.027. PubMed PMID: 28340829.

129.     Erdem Kivrak E, Atalay Şahar E, Can H, Döşkaya M, Yilmaz M, Pullukçu H, Caner A, Töz H, Gürüz AY, Işikgöz Taşbakan M. Screening of immunocompromised patients at risk of strongyloidiasis in western Turkey using ELISA and real-time PCR. Turk J Med Sci. 2017 Jun 12;47(3):897-901. doi: 10.3906/sag-1605-19. PubMed PMID:28618740.

130.     Ok E, Levin NW, Asci G, Chazot C, Toz H, Ozkahya M. Interplay of volume, blood pressure, organ ischemia, residual renal function, and diet: certainties and uncertainties with dialytic management. Semin Dial. 2017 Sep;30(5):420-429. doi: 10.1111/sdi.12612. Epub 2017 Jun 5. Review. PubMed PMID: 28581677.

131.     Yılmaz M, Gökengin D, Bozbıyık O, Hoşcoşkun C, Uyan A, Töz H. Kidney Transplant in a Human Immunodeficiency Virus-Positive Patient: Case Report of Drug Interactions. Exp Clin Transplant. 2017 Sep 30. doi: 10.6002/ect.2017.0013. [Epub ahead of print] PubMed PMID: 289695

132.     Al-Daghri NM, Batzel JJ, Burgmann H, Carbone F, Charmandari E, Chrousos GP, Distelmaier K, Cvirn G, Dullaart RPF, Dumitrascu DL, Esteve-Pastor MA, Gervasini G, Goliasch G, Goswami N, Gruppen EG, Hernández-Mijares A, Kalantaridou SN,Krause R, Latini R, Makrigiannakis A, Marín F, Masson S, Montecucco F, NdrepepaG, Nicolaides NC, Novelli D, Orasan OH, Qorbani M, Ratzinger F, Roessler A,Sabico S, Sciatti E, Stefanaki C, Stoner L, Tabatabaei-Malazy O, Tatar E, Toz H, Uslu A, Victor VM, Vizzardi E. Research update for articles published in EJCI in 2015. Eur J Clin Invest. 2017 Oct;47(10):775-788. doi: 10.1111/eci.12819. PubMed PMID: 28960328.

133. Yazici B, Oral A, Yilmaz M, Akgün A, Toz H. Two Different Causes of Decreased Activity on Ipsilateral Iliac Artery in Renal Transplant Scintigraphy. Clin Nucl Med. 2018 Jul;43(7):540-541. doi: 10.1097/RLU.0000000000002120. PMID: 29742601.

134. Üstün M, Alçı E, Budak S, Demir HB, Yucel C, Şen S, Yilmaz M, Töz H. Evaluation of Cases of Graft Nephrectomy After Graft Loss in Patients With Renal Transplantation. Transplant Proc. 2018 Dec;50(10):3445-3448. doi: 10.1016/j.transproceed.2018.07.030. Epub 2018 Aug 9. PMID: 30577219.

135. Bulut IK, Taner S, Keskinoglu A, Toz H, Sarsik B, Sezer TO, Kabasakal C. Long-Term Follow-up Results of Renal Transplantation in Pediatric Patients With Focal Segmental Glomerulosclerosis: A Single-Center Experience. Transplant Proc. 2019 May;51(4):1064-1069. doi: 10.1016/j.transproceed.2019.01.096. Epub 2019 Feb 8. PMID: 31101172.

136. Günay E, Çelebi T, Şen S, Aşcı G, Sarsik Kumbaraci B, Gökalp C, Yılmaz M, Töz H. Investigation of the Factors Affecting Allograft Kidney Functions: Results of 10 Years. Transplant Proc. 2019 May;51(4):1082-1085. doi: 10.1016/j.transproceed.2019.02.014. Epub 2019 Feb 21. PMID: 31101175.

137. Günay E, Zeytinoğlu A, Şen S, Yılmaz M, Atay G, Aşcı G, Sezer TO, Töz H. Do Antithymocyte Globulin-Free Acute Rejection Therapies Increase the Risk of Polyoma Nephropathy in Renal Transplant Recipients? Transplant Proc. 2019 May;51(4):1112-1114. doi: 10.1016/j.transproceed.2019.01.109. Epub 2019 Feb 8. PMID: 31101182.

138. Hortu I, Arı SA, Akdemir A, Koroglu OA, Yılmaz M, Toz H, Sagol S, Ergenoglu AM. Perinatal outcomes of renal transplant pregnancies: a 22-year experience at a single tertiary referral center. J Matern Fetal Neonatal Med. 2020 Sep;33(17):3028-3034. doi: 10.1080/14767058.2019.1639664. Epub 2019 Jul 9. PMID: 31288677.

139. Danış N, Toz H, Ünal N, Yılmaz M, Turan İ, Günşar F, Karasu Z, Ersöz G, Özkahya M, Akarca US. Paritaprevir, ritonavir, ombitasvir, and dasabuvir treatment in renal transplant patients with hepatitis C virus infection. Turk J Gastroenterol. 2019 Aug;30(8):695-701. doi: 10.5152/tjg.2019.18833. PMID: 31418413; PMCID: PMC6699569.

140. Gokalp C, Guner Oytun M, Gunay E, Dogdus M, Sezis Demirci M, Sen S, Tamsel S, Sezer TO, Toz H. Increase in interventricular septum thickness may be the first sign of cardiovascular change in kidney donors. Echocardiography. 2020 Feb;37(2):276-282. doi: 10.1111/echo.14593. Epub 2020 Jan 19. PMID: 31955456.

141. Gokalp C, Oytun MG, Gunay E, Tamsel S, Sen S, Sezer TO, Toz H. Acoustic Radiation Force Impulse Elastography May Predict Acute Rejection in Kidney Transplantation. Transplant Proc. 2020 Dec;52(10):3097-3102. doi: 10.1016/j.transproceed.2020.02.174. Epub 2020 Jun 4. PMID: 32507711.

142. Celtik A, Sen S, Keklik F, Saydam G, Asci G, Sarsik B, Ozkahya M, Toz H. A histopathological scoring and grading system to predict outcome for patients with AA amyloidosis. Int Urol Nephrol. 2020 Jul;52(7):1297-1304. doi: 10.1007/s11255-020-02505-y. Epub 2020 Jun 11. PMID: 32529382.

143. Bilgi A, Gökulu ŞG, İlgen O, Kulhan M, Akgün Kavurmacı S, Toz H, Terek MC. Cervical dysplasia after renal transplantation: A retrospective cohort study. Turk J Obstet Gynecol. 2021 Mar 12;18(1):7-14. doi: 10.4274/tjod.galenos.2021.28938. PMID: 33715321; PMCID: PMC7962164.